Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00077298
Status:
COMPLETED
Last Update Posted:
2015-04-15
First Post:
2004-02-10
Brief Title:
Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IVB Rectal Cancer |
| Recurrent Colon Cancer |
| Recurrent Rectal Cancer |
| Stage IVA Colon Cancer |
| Stage IVA Rectal Cancer |
| Stage IVB Colon Cancer |
Keywords: